See also this year's filing and all EDGAR filings for this company.
PDF Report 0001340652_2021_Chemocentryx_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001340652, Chemocentryx Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 441,570,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 25,160,000 |
| 3 | remainder_Assets | 52,169,000 |
| 4 | LiabilitiesCurrent | 51,558,000 |
| 5 | LiabilitiesNoncurrent | 19,057,000 |
| 6 | remainder_Liabilities | 62,671,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 78,810,414 |
| 9 | ResearchAndDevelopmentExpense | 79,852,007 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 58,651,624 |
| 12 | remainder_NetIncome | 260,073 |
| 13 | remainder_ComprehensiveNetIncome | 513,988 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 518,899,000 |
| 1 | Liabilities | 133,286,000 |
| 2 | Expenses | 158,662,421 |
| 3 | Revenues | 58,651,624 |
| 4 | StockholdersEquity | 385,613,000 |
| 5 | NetIncome | -99,750,724 |
| 6 | ComprehensiveNetIncome | -99,493,730 |
| 7 | BaseVar | 435,136,553 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.27 |
| 9 | EconomicCapitalRatio | 3.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
